SpassMed scores US FDA 510(k) for AI sepsis detection software

South Korean medical AI company SpassMed has received the United States Food and Drug Administration's 510(k) clearance for its AI-powered sepsis detection software. 

The AI solution called SpassageQ has been approved as software as a medical device for identifying sepsis, anaphylaxis, and hypovolemic shock. 

South Korean researchers use AI to predict immunotherapy side effects 

Researchers from various South Korean universities have teamed up to develop an AI model for predicting the side effects of immunotherapy on cancer patients. 

Korea Advanced Institute of Science and Technology and Asan Medical Center first came up with a comprehensive list of risk factors of the side effects of immuno-oncology drugs based on patients' genomes, transcriptomes, and blood indicators. This was extracted from a large-scale prospective cohort of solid cancer patients, in partnership with nine South Korean medical institutions. 

From this, a deep learning prediction model was developed that determines whether a patient will show side effects to immunotherapy prior to getting it. 

The research was done given the lack of understanding of such side effects, which have been found to be similar to autoimmune diseases, and in the worst case, can even lead to death.

Fujifilm India launches mobile app for providers

Fujifilm India has launched a mobile app where healthcare providers can manage the service and support for their medical diagnostic devices.

Available on iOS and Android phones, Fujifilm Connect allows the submission and tracking of service requests, viewing of maintenance records, and monitoring of device performances. It also has features that aid in customer support services, such as a 24/7 call logging process and real-time contract status visibility. 

KT Corp. to develop Vietnamese medical info platform with Dong-A ST

Telecommunications giant KT Corporation from South Korea is collaborating with Dong-A ST, a pharmaceutical company in Vietnam, to create a medical information platform in the Vietnamese language. 

The partnership aims to create content about South Korean medical technology for Vietnamese medical workers. According to a media release, the platform is targeted to be released in July. 

TatvaCare to launch clinical trial of COPD DTx 

Indian health tech company TatvaCare is launching a clinical trial of its digital therapeutic solution, MyTatva, for people with chronic respiratory disorders.

The digital-based solution MyTatva combines personalised care plans, IoT device monitoring, coaching, and counselling services to improve patients' compliance with their care programme. 

According to a press release, the BREATHE DTx trial seeks to test the efficacy and acceptability of the DTx for COPD and asthma. It will also gauge its capability to reduce exacerbations and incidents. 

For six months, it will be conducted across eight settings in India and will involve up to 200 participants.